Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
今後の臨床試験
-
Shirley Ryan AbilityLabKiwanis Neurological Research Foundation募集
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)まだ募集していません
-
Fundacion para la Investigacion Biomedica del Hospital...Hospital Universitario La Fe募集
-
Lumetry Diagnostics GmbHKarl Landsteiner Institute for Lung Research and Pneumological Oncology; Klinik Floridsdorfまだ募集していません
-
Beijing Suncadia Pharmaceuticals Co., Ltd募集
-
Xiangya Hospital of Central South Universityまだ募集していません
-
Halic Universityまだ募集していません睡眠の質 | 食事介入 | 知覚ストレス | 物忘れトルコ(Türkiye)
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universityまだ募集していません転移性乳がん | ホルモン受容体陽性乳がん | HER2-low 乳がん中国
-
The 108 Military Central HospitalVietnam Military Medical University; Thanh Phuong Co., Ltdまだ募集していません
-
University Hospital, Montpellierまだ募集していません
-
Kasr El Aini Hospital募集